Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Issue 2 (6th December 2021)

• Record Type: Journal Article
• Authors: Shi, Jiaying; Qin, Xiaohui; Chang, Xueli; Wang, Hong; Guo, Junhong; Zhang, Wei
• Is Part Of: Journal of cellular and molecular medicine. Volume 26:Issue 2(2022)
• Page Start: 583
• Page End: 587
• Publication Date: 2021-12-06
• Subjects: amyotrophic lateral sclerosis -- axonal damage -- biomarker -- neurofilament light chain -- phosphorylated neurofilament heavy chain; Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.17100
• Languages: English
• ISSNs: 1582-1838

Abstract

Abstract: This study aims to determine the serum and cerebrospinal fluid (CSF) levels of neurofilament light chain (NFL) and phosphorylated neurofilament heavy chain (pNFH) in amyotrophic lateral sclerosis (ALS) patients, and to explore their feasibility as valid biomarkers for quantifying disease progression and predicting individual prognosis. 52 patients with ALS and 30 controls with noninflammatory neurological diseases were included. NFL and pNFH levels in serum and CSF were measured by enzyme‐linked immunosorbent assay. Our findings showed that serum and CSF levels of NFL and pNFH in ALS patients were significantly increased. These values were negatively correlated with disease duration (except CSF NFL with disease duration) and ALSFRS‐r score, and positively correlated with disease progression rate (DPR) and upper motor neuron (UMN) score, but did not correlate with bilateral median and ulnar nerve compound muscle action potential (cMAP) amplitudes (except a weak correlation between CSF NFL and cMAP amplitudes). The optimal cut‐off values with high sensitivity and specificity were obtained in ROC curve analysis to discriminate ALS from controls. Kaplan‐Meier survival curves illustrated that survival was significantly shorter for patients with higher neurofilament levels at diagnosis. The Cox proportional hazards regressions confirmed that NFL and pNFH were significant predictors of survival. Overall, NFL and pNFH in serum and CSF can be used as reliable biomarkers in ALS.